H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 87 Citations 31,150 317 World Ranking 6882 National Ranking 3792

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Alzheimer's disease
  • Disease

Gil D. Rabinovici mainly investigates Alzheimer's disease, Neuroscience, Pathology, Dementia and Atrophy. Specifically, his work in Alzheimer's disease is concerned with the study of Pittsburgh compound B. His research integrates issues of Corticobasal degeneration and Disease in his study of Neuroscience.

His Pathology course of study focuses on Precuneus and Early-onset Alzheimer's disease and Cardiology. His work carried out in the field of Dementia brings together such families of science as Apolipoprotein E and Degenerative disease. He has researched Atrophy in several fields, including Cerebral cortex, Biomarker, Alzheimer's Disease Neuroimaging Initiative and Central nervous system disease.

His most cited work include:

  • Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria (1750 citations)
  • Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins (879 citations)
  • Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease (665 citations)

What are the main themes of his work throughout his whole career to date?

Gil D. Rabinovici spends much of his time researching Pathology, Disease, Alzheimer's disease, Dementia and Neuroscience. His Disease research is multidisciplinary, incorporating elements of Biomarker, Cognition and Neuroimaging. He combines subjects such as Positron emission tomography, Precuneus and Posterior cortical atrophy with his study of Alzheimer's disease.

His Dementia study incorporates themes from Cognitive impairment, Oncology, Psychiatry, Neurology and Amyloid. His is doing research in Default mode network and Human brain, both of which are found in Neuroscience. His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology, Hyperintensity and Cardiology.

He most often published in these fields:

  • Pathology (57.08%)
  • Disease (40.66%)
  • Alzheimer's disease (46.20%)

What were the highlights of his more recent work (between 2020-2021)?

  • Disease (40.66%)
  • Dementia (36.55%)
  • Internal medicine (30.80%)

In recent papers he was focusing on the following fields of study:

His main research concerns Disease, Dementia, Internal medicine, Cognition and Biomarker. The Disease study combines topics in areas such as Cerebral cortex, Neuroimaging and Distribution. His Dementia research is multidisciplinary, relying on both Odds ratio, Positron emission tomography, Cognitive impairment and Amyloid.

His Cognition study is concerned with the larger field of Neuroscience. His research in Neuroscience intersects with topics in Diaschisis and Primary progressive aphasia. Gil D. Rabinovici works mostly in the field of Alzheimer's disease, limiting it down to concerns involving Temporal lobe and, occasionally, Apolipoprotein E.

Between 2020 and 2021, his most popular works were:

  • Spatial Relationships between Molecular Pathology and Neurodegeneration in the Alzheimer's Disease Continuum. (6 citations)
  • The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update (5 citations)
  • Association Between Ambient Air Pollution and Amyloid Positron Emission Tomography Positivity in Older Adults With Cognitive Impairment. (3 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Alzheimer's disease

His primary areas of study are Disease, Tau pathology, Biomarker, Dementia and Comorbidity. His biological study spans a wide range of topics, including Cerebral cortex, Cognition, Neuroscience and Pathological staging. His Dementia research incorporates themes from Odds ratio, Cognitive impairment and Amyloid.

The various areas that Gil D. Rabinovici examines in his Odds ratio study include Medical diagnosis, Population ageing, Rate ratio, Alzheimer's disease and Positron emission tomography. His Cognitive impairment research entails a greater understanding of Pathology. His Amyloid study deals with the bigger picture of Internal medicine.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

Bruno Dubois;Bruno Dubois;Howard H Feldman;Claudia Jacova;Harald Hampel;Harald Hampel.
Lancet Neurology (2014)

2389 Citations

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

Sandip Ray;Markus Britschgi;Charles Herbert;Yoshiko Takeda-Uchimura.
Nature Medicine (2007)

1149 Citations

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.

Bruno Dubois;Harald Hampel;Harald Hampel;Howard H. Feldman;Philip Scheltens.
Alzheimers & Dementia (2016)

845 Citations

Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease

Juan Zhou;Michael D. Greicius;Efstathios D. Gennatas;Matthew E. Growdon.
Brain (2010)

807 Citations

Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

Günter U Höglinger;Gesine Respondek;Maria Stamelou;Carolin Kurz.
Movement Disorders (2017)

729 Citations

PET Imaging of Tau Deposition in the Aging Human Brain

Michael Schöll;Michael Schöll;Samuel N. Lockhart;Daniel R. Schonhaut;James P. O’Neil.
Neuron (2016)

664 Citations

Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjects

E. C. Mormino;J. T. Kluth;C. M. Madison;G. D. Rabinovici;G. D. Rabinovici;G. D. Rabinovici.
Brain (2009)

664 Citations

Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.

Rik Ossenkoppele;Rik Ossenkoppele;Rik Ossenkoppele;Daniel R. Schonhaut;Daniel R. Schonhaut;Michael Schöll;Michael Schöll;Samuel N. Lockhart.
Brain (2016)

604 Citations

Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management.

Gil D. Rabinovici;Bruce L. Miller.
CNS Drugs (2010)

601 Citations

Aβ amyloid and glucose metabolism in three variants of primary progressive aphasia

Gil D Rabinovici;William J Jagust;Ansgar J Furst;Ansgar J Furst;Jennifer M Ogar;Jennifer M Ogar.
Annals of Neurology (2008)

486 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Gil D. Rabinovici

Kaj Blennow

Kaj Blennow

University of Gothenburg

Publications: 428

Henrik Zetterberg

Henrik Zetterberg

University of Gothenburg

Publications: 392

Philip Scheltens

Philip Scheltens

Vrije Universiteit Amsterdam

Publications: 190

John R. Hodges

John R. Hodges

University of Sydney

Publications: 189

Bruce L. Miller

Bruce L. Miller

University of California, San Francisco

Publications: 184

William J. Jagust

William J. Jagust

Helen Wills Neuroscience Institute

Publications: 184

Clifford R. Jack

Clifford R. Jack

Mayo Clinic

Publications: 171

Reisa A. Sperling

Reisa A. Sperling

Brigham and Women's Hospital

Publications: 170

James B. Rowe

James B. Rowe

University of Cambridge

Publications: 165

Ronald C. Petersen

Ronald C. Petersen

Mayo Clinic

Publications: 153

Keith A. Johnson

Keith A. Johnson

Harvard University

Publications: 139

Frederik Barkhof

Frederik Barkhof

University College London

Publications: 137

Oskar Hansson

Oskar Hansson

Lund University

Publications: 136

Giovanni B. Frisoni

Giovanni B. Frisoni

University of Geneva

Publications: 133

Rik Ossenkoppele

Rik Ossenkoppele

Lund University

Publications: 132

Keith A. Josephs

Keith A. Josephs

Mayo Clinic

Publications: 127

Something went wrong. Please try again later.